Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sarah Muench"'
Publikováno v:
MedEdPORTAL, Vol 14 (2018)
Introduction Following the release of the Centers for Disease Control and Prevention guidelines in 2016, institutions are encouraged to have controlled substance agreements that require the use of drug screens for appropriate opioid prescribing. Corr
Externí odkaz:
https://doaj.org/article/12dc6177b89244db859bfe359e667b50
Publikováno v:
Journal of the American Pharmacists Association. 62:1792-1798
Urgent care medicine is a rapidly growing health care sector where patients are commonly treated for acute infectious diseases-related conditions. However, there are few antimicrobial stewardship interventions described in these settings.The objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::250e121c4cb36f41f739324eac933a54
https://doi.org/10.1016/j.japh.2022.06.004
https://doi.org/10.1016/j.japh.2022.06.004
Publikováno v:
Hosp Pharm
Background and Objectives: To assess the impact that pharmacist education has on proper inhaler technique and adherence in a teaching clinic. Methods: This was prospective, non-randomized, pre-test/post-test study. Patients were 18 years or older, ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2024a7f20bb0ec0e96233986469a6987
https://europepmc.org/articles/PMC9125121/
https://europepmc.org/articles/PMC9125121/
Autor:
Nadia J, Aneese, Alexandra, Halalau, Sarah, Muench, Daniel, Shelden, Janna, Fett, Colleen, Lauster
Publikováno v:
The American journal of managed care. 24(4 Spec)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::417d9b468450115ece5c447f007de246
https://pubmed.ncbi.nlm.nih.gov/29689147
https://pubmed.ncbi.nlm.nih.gov/29689147
Publikováno v:
American Journal of Health-System Pharmacy. 64:1265-1273
Purpose. The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and role in therapy of vildagliptin for the treatment of type 2 diabetes mellitus were reviewed. Summary. Vildagliptin is an agent in a new class of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed40e433cbdc7d7a358f297340dfb0af
https://doi.org/10.2146/ajhp060564
https://doi.org/10.2146/ajhp060564